Financial Architects (New Jersey)’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-100
Closed 1226
2019
Q1
$0 Hold
100
﹤0.01% 1426
2018
Q4
$0 Hold
100
﹤0.01% 1346
2018
Q3
$1K Hold
100
﹤0.01% 1354
2018
Q2
$0 Hold
100
﹤0.01% 1348
2018
Q1
$0 Hold
100
﹤0.01% 1407
2017
Q4
$0 Hold
100
﹤0.01% 1494
2017
Q3
$1K Hold
100
﹤0.01% 1444
2017
Q2
$1K Hold
100
﹤0.01% 1470
2017
Q1
$1K Sell
100
-500
-83% -$2.93K ﹤0.01% 1507
2016
Q4
$3K Hold
600
﹤0.01% 1227
2016
Q3
$4K Hold
600
﹤0.01% 1181
2016
Q2
$5K Buy
+600
New +$5.74K ﹤0.01% 1110

Other funds holding CATX

Financial Architects (New Jersey)'s CATX Position: Q2 2019 in Review

Financial Architects (New Jersey) sold out of Perspective Therapeutics (CATX) in Q2 2019, closing a stake of 100 shares.

Financial Architects (New Jersey) first reported a position in CATX in Q2 2016 and held it in 12 quarters. The position peaked at $5K in Q2 2016. 29 funds tracked by Wall St. Rank hold CATX as of Q2 2019.

  • Financial Architects (New Jersey) reported no remaining Perspective Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 100 Perspective Therapeutics shares in Q2 2019.
  • Financial Architects (New Jersey) first reported a position in Perspective Therapeutics in Q2 2016 and held it in 12 quarters.
  • Financial Architects (New Jersey)'s Perspective Therapeutics position peaked at $5K in Q2 2016.
  • 29 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2019, filed 14 Aug 2019.